Formoterol is a long-acting beta-2 adrenergic agonist primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). It functions by relaxing the muscles of the airways, leading to bronchodilation and improved airflow. Formoterol is characterized by its rapid onset of action, typically within minutes, and a prolonged duration of effect, lasting up to 12 hours or more. This makes it suitable for both maintenance therapy and as a rescue medication in certain situations. The substance is usually administered via inhalation, often in combination with corticosteroids to enhance its therapeutic effects. Formoterol is known for its relatively favorable safety profile, although potential side effects may include tremors, palpitations, and headaches. It is important to note that while formoterol can relieve symptoms, it is not intended for the treatment of acute asthma attacks. As with any medication, it should be used under the guidance of a healthcare professional to ensure proper dosing and to monitor for any adverse effects.

formoterol

128954-45-0: Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-

Formoterol (Mixture of Diastereomers)

Applications Formoterol is a selective β2-adrenergic receptor agonist. Formoterol is used as an antiasthmatic.
References Yoshida, T., et al.: Pharmacometrics, 26, 811 (1983), Bartow, R.A., et al.: Drugs, 55, 303 (1998)


CAS 128954-45-0: formoterol

Formoterol (Mixture of Diastereomers)

Ref: 4Z-F-1150

Formoterol (mixture of Diastereomers)

Ref: TR-F693395